| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99233 |
Prolong inpt eval add15 m |
6,716 |
2,540 |
$294K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,092 |
5,027 |
$286K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,572 |
6,491 |
$254K |
| 94726 |
|
3,617 |
3,394 |
$181K |
| 94060 |
|
3,669 |
3,445 |
$172K |
| 94729 |
|
3,311 |
3,209 |
$163K |
| 94642 |
|
1,739 |
1,738 |
$132K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,204 |
1,202 |
$116K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
1,687 |
776 |
$44K |
| 99223 |
Prolong inpt eval add15 m |
537 |
515 |
$39K |
| 99243 |
|
177 |
175 |
$12K |
| 94618 |
|
296 |
296 |
$10K |
| 99255 |
|
71 |
70 |
$6K |
| 94728 |
|
463 |
452 |
$4K |
| 94200 |
|
457 |
455 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
24 |
24 |
$2K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
13 |
13 |
$1K |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
1,706 |
1,703 |
$804.74 |
| 94010 |
|
703 |
626 |
$777.90 |
| 99215 |
Prolong outpt/office vis |
14 |
14 |
$463.84 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
453 |
347 |
$312.88 |
| 94760 |
|
1,567 |
1,545 |
$138.95 |